UK biosolutions eye growth as resource insecurity sharpens

The UK biosolutions sector has raised £1.46 billion in equity since 2018, establishing itself as a key industry for domestic, biology-based alternatives to resource-intensive and imported systems. Despite a recent dip in investment, global capital—particularly from the US and Europe—continues to flow into the sector, reflecting confidence in the UK's scientific and entrepreneurial strengths. Regulatory barriers remain the main challenge, especially for early-stage companies, with calls for reform to unlock further growth. The sector is increasingly viewed as crucial for national resilience, economic security, and strategic autonomy amid global supply chain volatility.